Print Page   |   Contact Us   |   Sign In   |   Register
Program - Session Descriptions
Share |


 Fees arrow  Register
arrow Program
arrow Faculty
arrow CNE
arrow Travel & Hotel
arrow Abstracts
arrow Exhibitor

CONFERENCE PROGRAM

Wednesday, May 29

10:00 AM–6:00 PM Registration Open

Preconference Workshops

1:00–5:00 PM Afternoon Programs (3.75 contact hours)

010

Neonatal Pharmacology Update 2019

What Keeps a Clinical Pharmacist Up at Night? Unanswered Questions
Jim Thigpen, PharmD, BCPS
Dr. Thigpen explores some of the neonatal disease processes that continue to frustrate clinicians despite continual research. He takes a brief look at historical therapy and then discuss the current regimens as well as the forecast of future treatment. Topics will include NEC, BPD, HIE, and pulmonary hypertension, among others. 

Antenatal Late Preterm Steroids and Neonatal Effects of Antenatal Magnesium Sulfate
Patricia J. Johnson, DNP, MPH, APRN, NNP

Dr. Johnson explores the current recommendations for administration of steroids to the mother for planned delivery prior to 37 completed weeks, including the known benefits, contraindications, and potential complications of broadening the recommendations for steroids to the late preterm, 34–36 6/7 weeks. She also presents the indications for antenatal magnesium sulfate administration including for neuroprotection of the very low birth weight infant and discusses the potential benefits and complications.

NCC NIC Code 3
NCC NNP Code 4

Rx = 3.75

020

Neonatal Palliative Care in the NICU
Victoria Kain, RN, MN, NICC, PhD
In this in-depth workshop, participants will have the opportunity to work through practical examples of caring for newborns who are not expected to survive. Dr. Kain explores ethical issues, pharmacologic and non-pharmacologic approaches to symptom management, developing communication skills to work with parents, the nursing role in decision making, and conflict resolution using a graded assertiveness approach.

NCC NIC Code 2
NCC NNP Code 3

Rx = 1

030

RNC-NIC Certification Mini Review
Robin Koeppel, DNP, RNC-NIC, CPNP, CNS
Andrea C. Morris, DNP, RNC-NIC, CCRN, CNS

This RNC-NIC Certification Mini-Review is a fast-paced course with an emphasis on major body systems often included on the certification exam including respiratory, cardiac, gastrointestinal, and neurological. Also included are quick-fire questions and answers on fluid and electrolytes and hematology.

NCC NIC Code 4
NCC NNP Code 5

040

Student Capstone Project Showcase - NEW!
NNP Student Capstone projects including case studies, quality improvement projects, and research are presented. A portion of the afternoon will feature selected podium presentations followed by a presentation of student posters. Prizes will be given for the best podium and poster presentation in the Student Showcase.

NCC NIC Code 4
NCC NNP Code 5


Thursday, May 30

6:45 AM – 4:45 PM Registration Open

7:15 AM - 7:45 AM Coffee and Tea Service

General Sessions

7:45–8:00 AM Welcome/General Announcements 
8:00–9:00 AM

GS 101

A Skeptic’s View of Neonatal Care: Balancing Science and Art
Richard Polin, MD
The goal of every nurse and doctor is to provide the best possible care to their patients and of course never do harm to anyone. Fundamental to this concept of “doing good” is acquisition of knowledge. Much of that information is acquired during training with experienced individuals; however, “new information” is learned from seminars, books, and journals. Unfortunately, incorrect data can lead to errors in care that can be detrimental for our critically ill infants. Good health care providers learn to use both individual clinical expertise and the best available external evidence to make decisions; neither alone, is enough.

NCC NIC Code 4
NCC NNP Code 5

9:00–10:00 AM

GS 102

High Velocity Nasal Insufflation and CPAP: How are They Different and What are the Similarities?

Michael McQueen, MD
High velocity nasal insufflation (HVNI) is a unique form of non-invasive ventilatory support in spontaneously breathing patients. The mechanisms of action are not pressure-based. HVNI has proven non-inferior to CPAP in multiple randomized controlled trials. Dr. McQueen discusses these important ventilatory modalities, among others.


NCC NIC Code 1
NCC NNP Code 2

10:00–11:15 AM Exhibits Open—Please Visit Exhibits and Posters (Coffee, Tea)
11:15 AM – 12:15 PM

GS 103

Stem Cell Therapies for Hypoplastic Left Heart Syndrome
Ram Kumar Subramanyan, MD, PhD
In infants with hypoplastic left heart syndrome (HLHS), the left ventricle of the heart does not develop appropriately; the right side of the heart must perform “double duty,” pumping blood both to the lungs and to the body. This added work strains the heart and by adolescence the heart can begin to weaken and even fail, causing some children to require a heart transplant. By injecting the infant’s own stem cells into the right heart, the hope is that these cells will serve as a fertilizer to make new heart muscle cells so the heart does not weaken or fail. Dr. Subramanyan explores these new therapies.

NCC NIC Code 2
NCC NNP Code 2

12:15–1:30 PM Lunch in Exhibit Hall Provided by ANN
1:30–2:30 PM

GS 104

Hot Topics in Neonatal Infectious Disease
Jim Thigpen, PharmD, BCPS
In this discussion, Dr. Thigpen includes new treatments for old pathogens as well as the reemergence of some old medications. A look at technology that is being developed and may have application in the NICU is also discussed.

NCC NIC Code 2
NCC NNP Code 2

Rx = 1

2:30–3:30 PM Refreshment BreakPlease Visit Exhibits and Posters (Lemonade, Iced Tea)
3:30–4:30 PM

GS 105 

Perinatal and Delivery Room Management of Complex CHD
Jay Pruetz, MD
Dr. Pruetz covers the spectrum of critical congenital heart disease from prenatal detection to perinatal coordination of care and immediate management in the delivery room. Focusing on CHD lesions with the highest risk for emergent neonatal care, he discusses a CHD risk stratification system with level of care assignments and specific neonatal management recommendations.

NCC NIC Code 2
NCC NNP Code 2

 

Friday, May 31

6:30 AM–3:30 PM Registration Open

7:00–8:00 AM Breakfast in Exhibit Hall

General Sessions

8:00–9:00 AM

GS 201

Paradigm Shifts for the Hemodynamic Management of Neonatal Septic Shock in 2019
Amir Ashrafi, MD
Dr. Ashrafi discusses the structure of the neonatal myocardium and the vascular endothelium. He explores state-of-the-art assessment of hemodynamics in septic shock and presents algorithms to restore hemodynamic stability.

NCC NIC Code 2
NCC NNP Code 2

9:00–10:00 AM

GS 202

Benefits of Human Milk: and the Role of Oligosaccharides
Lars Bode, PhD
Dr. Bode describes benefits of human milk and specifically focuses on how oligosaccharides contribute to these benefits. He defines human milk oligosaccharides (HMOs) and outlines several potential mechanisms through which HMOs can impact infant and health and development.

NCC NIC Code 1
NCC NNP Code 3

10:00–11:15 AM Refreshment Break—Visit Exhibits and Posters (Coffee, Tea)
Last Chance to Visit Exhibits, Poster Presenters will be at their posters to answer questions and discuss their work.
11:15 AM–12:15 PM

GS 203

Fetal Surgery
Ramen H. Chmait, MD
Over the past several decades society has been witness to a transformation in its view of the fetus as a patient. This in part is due to high-resolution obstetrical ultrasound and other prenatal screening and diagnostic techniques that have allowed us to better understand fetal conditions. The open fetal surgical approach has slowly given way to minimally invasive surgical access into the womb, so there is minimal disturbance to the pregnancy and the mother. Dr. Chmait discusses the pros and cons of open versus minimally invasive fetal surgery and highlights representative fetal conditions potentially amenable to fetal therapy.

NCC NIC Code 1
NCC NNP Code 1

12:15–1:30 PM
Lunch on your own
1:30–2:30 PM A Workshops Concurrent Sessions

211

Interventions to Prevent BPD: What Does the Future Hold?
Richard Polin, MD
Bronchopulmonary dysplasia (BPD) is the most common, serious complication of neonatal intensive care. Unfornately, the incidence of bronchopulmonary dysplasia has been unchanged over the past decade. The evidence-based strategies for decreasing the risk BPD include, use of non-invasive ventilation, vitamin A, caffeine, and postnatal steroids. Dr. Polin addresses three other potential strategies to decrease the risk of chronic lung disease, including the earlier administration of caffeine, less invasive surfactant administration (LISA) and sustained lung inflation. The difficulty of performing a gentle resuscitation in a infant with a fluid-filled lung is also discussed. 

NCC NIC Code 2
NCC NNP Code 2

Rx = 0.5

212

Innovations in Fetal Cardiac Intervention
Jay Pruetz, MD
Dr. Pruetz examines the current approach to prenatal diagnoses that can be treated with fetal cardiac intervention (FCI). He discusses several examples of FCI cases and includes indications for intervention, predictors of success, and anticipated outcomes. He also introduces several current areas of study for novel fetal interventions aimed at improving the lives of infants with congenital heart disease.

NCC NIC Code 2
NCC NNP Code 2

213

A to Zinc: The Why, When, and How of Vitamin Supplementation in the NICU

Nathan Lepp, MD, MPH
Vitamin and other supplementation is of critical importance for the ill infant in the neonatal intensive care unit. Dr. Lepp discusses the basic physiology of some of the most important supplements. He explores the most recent evidence on supplementation in the NICU. Attendees will leave this session with tools to develop an evidence-based approach to supplementation in their own practice.

NCC NIC Code 1
NCC NNP Code 3

Rx = 0.75

214

Podium Presentations
This session has multiple presenters. These cutting-edge abstract presentations will bring you up-to-date on innovative research and clinical practice projects. 

NCC NIC Code 4
NCC NNP Code 5

2:45–3:45 PM B Workshops Concurrent Sessions 

221
What is the Role of Oligosacchrides in Neonatal Disease?
Lars Bode, PhD
In this workshop, Dr. Bode introduces human milk oligosaccharides (HMOs) and showcases how they contribute to the beneficial effects of human milk feeding in preterm infants at risk of developing necrotizing enterocilitis, a common and often fatal disorder affecting the intestine of preterm infants.

NCC NIC Code 1
NCC NNP Code 3

Rx = 

222

Family-Centered NAS Care: Using Eat, Sleep, and Console
Lisa Grisham, MS, NNP-BC 
Come learn how to implement a family-centered care program for infants affected by neonatal abstinence syndrome (NAS) using the Eat, Sleep, and Console (ESC) approach. Ms. Grisham covers the scope of the problem, approaches to manage NAS, the ESC approach, and results from Banner University Medical Center's Family-Centered NAS Care Program.

NCC NIC Code 1
NCC NNP Code 2

223
NICU Length of Stay: How Can We Shorten It?
Joseph Kaempf, MD
Why is there so much variation among NICUs’ length of stay (LOS)? Even after risk-adjustment, some NICUs are much more proficient and efficient at caring for newborns and transitioning them home. Length of stay is by far the leading cost indicator for NICUs and there are several reliable strategies available to reduce unnecessary hospital stay time and thus provide innovative value. Dr. Kaempf discusses how NICUs can implement evidence-based, practical strategies that reduce waste and improve safety and family satisfaction.

NCC NIC Code 4
NCC NNP Code 5

224

Podium Presentations
This session has multiple presenters. These cutting-edge abstract presentations will bring you up-to-date on innovative research and clinical practice projects.

NCC NIC Code 4
NCC NNP Code 5


Saturday, June 1
7:00 AM–12:30 PM Registration Open

7:30–8:00 AM Coffee and Tea Service

General Sessions

8:00–9:00 AM

GS 301
Isn't Every NICU a Neuro-NICU?
Kathi S. Randall, RNC, MSN, NNP-BC
Neuro-NICUs are a growing trend around the globe. Their implementation and scope of practice, however, is highly variable. Ms. Randall shares her experience helping nurses in NICUs around the globe integrate the four pillars of neurointensive care into their practice. A cornerstone of any Neuro-NICU is neuroprotective and neurodevelopmental support, and there are many simple practices you can integrate in to your daily practice to support families, their infants, and the infant’s rapidly developing brain. You will leave this presentation with the tools to turn any NICU in to a Neuro-NICU.

NCC NIC Code 4
NCC NNP Code 5

 9:00–9:15 AM Refreshment Break (Coffee, Tea)
 9:15–10:15 AM

GS 302

Intrauterine Drug Exposure: Not Just NAS
Nathan Lepp, MD, MPH
Infants are increasingly exposed to a wide variety of drugs in utero. While opioids and NAS continue to be of critical importance, other substances also have short- and long-term impacts on infants. In this case-based presentation with audience participation Dr. Lepp briefly touches on opioid exposure and the impacts on the infant. He then coverx a wide variety of other intrauterine exposures such as THC, methamphetamines, anxiolytics, and other substances. Participants learn about the effects on infants that may be present at birth as well as the long term consequences into childhood and beyond.

NCC NIC Code 1
NCC NNP Code 2

Rx = 0.25

10:15–11:15 AM

GS 303

What’s Right and What’s Wrong About CQI?
Joseph Kaempf, MD

What are the foundational principles of continuous quality improvement (CQI) that reliably transform the NICU into a culture of excellence? What are common pitfalls of CQI? What is the difference between truthful CQI strategies that work in the real world and directives that prove false, unproductive, and/or frustrating? Join Dr. Kaempf for this fascinating session that concludes the conference.
NCC NIC Code 4
NCC NNP Code 5

11:15–11:30 AM Conclusion


Topics and Speakers are Subject to Change

Top of Page

Return to Main Page

Community Search
Sign In